A detailed history of Swiss National Bank transactions in Biolife Solutions Inc stock. As of the latest transaction made, Swiss National Bank holds 71,900 shares of BLFS stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,900
Previous 71,100 1.13%
Holding current value
$1.92 Million
Previous $1.52 Million 18.12%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$19.19 - $26.52 $15,352 - $21,216
800 Added 1.13%
71,900 $1.8 Million
Q1 2024

May 07, 2024

BUY
$15.35 - $18.82 $38,375 - $47,050
2,500 Added 3.64%
71,100 $1.32 Million
Q4 2023

Feb 06, 2024

SELL
$8.99 - $16.86 $71,021 - $133,194
-7,900 Reduced 10.33%
68,600 $1.11 Million
Q3 2023

Nov 08, 2023

SELL
$10.81 - $22.96 $139,449 - $296,184
-12,900 Reduced 14.43%
76,500 $1.06 Million
Q2 2023

Aug 09, 2023

BUY
$17.19 - $24.34 $345,519 - $489,234
20,100 Added 29.0%
89,400 $1.98 Million
Q1 2023

May 10, 2023

SELL
$17.67 - $26.07 $137,826 - $203,346
-7,800 Reduced 10.12%
69,300 $1.51 Million
Q4 2022

Feb 08, 2023

BUY
$16.95 - $25.07 $28,815 - $42,619
1,700 Added 2.25%
77,100 $1.4 Million
Q3 2022

Nov 09, 2022

BUY
$14.64 - $26.7 $26,352 - $48,060
1,800 Added 2.45%
75,400 $1.72 Million
Q2 2022

Aug 09, 2022

BUY
$10.54 - $24.2 $152,830 - $350,900
14,500 Added 24.53%
73,600 $1.02 Million
Q1 2022

May 09, 2022

BUY
$20.81 - $37.29 $116,536 - $208,824
5,600 Added 10.47%
59,100 $1.34 Million
Q3 2021

Nov 08, 2021

SELL
$42.03 - $60.5 $176,526 - $254,100
-4,200 Reduced 7.28%
53,500 $2.26 Million
Q2 2021

Aug 06, 2021

SELL
$29.51 - $44.62 $64,922 - $98,164
-2,200 Reduced 3.67%
57,700 $2.57 Million
Q1 2021

May 07, 2021

BUY
$32.95 - $44.24 $39,540 - $53,088
1,200 Added 2.04%
59,900 $2.16 Million
Q4 2020

Feb 05, 2021

BUY
$27.5 - $45.75 $1.61 Million - $2.69 Million
58,700 New
58,700 $2.34 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.14B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.